Achieving Accurate Raw Images with High-content Screening
In this Labcompare editorial piece, Drug Discovery Sales Representative Shawn Nielsen Alvarado discusses the transformative impact of high-content screening (HCS) in cell-based assays, drug target discovery, functional assays, and toxicology studies.
She explores how HCS, with its end-to-end automation and advanced computational algorithms, accelerates scientific breakthroughs by providing rapid, reliable, and multiparametric analyses that push the boundaries of biomedical knowledge.